9月私募备案同比激增171%

Core Insights - In September, a total of 1,028 private securities products were registered, representing a 10.22% decrease from August's 1,145 products, but a significant year-on-year increase of 171.24% compared to 379 products in the same month of 2024 [1] Strategy Distribution - Among the registered products, equity strategies dominated with 668 products, accounting for 64.98% of the total. Multi-asset strategies followed with 155 products (15.08%), while bond strategies (71 products, 6.91%) and futures and derivatives strategies (69 products, 6.71%) were nearly equal in scale. Combination funds were relatively niche with 51 products (4.96%) [1][2] Quantitative Products Performance - Quantitative products showed strong performance in September, with 364 products registered, making up 35.41% of the total. Within this category, equity strategies contributed the most, with 166 long-only quantitative products (45.6%) and 69 market-neutral equity strategies (18.96%). In the futures and derivatives category, quantitative CTA strategies stood out with 45 products (12.36%) [2][3] Manager Distribution - The majority of registered products came from leading private equity firms, indicating a growing industry concentration. The top firm, Liwei Private Equity, registered 23 products, followed by Maoyuan Quantitative (13 products) and Yinye Investment (12 products). Among the 27 firms that registered at least five products, 16 were over 10 billion in assets, while 4 were between 5 billion and 10 billion, with top firms accounting for 74.07% of the total [3][4] Market Trends - Since the "9.24" market event, the profitability of equity markets has gradually become apparent, and policies continue to support sectors like technology innovation and high-end manufacturing. This has enhanced the appeal of equity strategies, leading to a rise in investor willingness to allocate to equity assets, thus maintaining high registration numbers for these strategies [4] Competitive Landscape - The registration advantages of leading private equity firms reflect resource aggregation. Large firms with assets over 10 billion have stronger research capabilities, risk control systems, and brand reputation, making it easier for them to gain recognition and funding. In contrast, smaller firms struggle with fundraising and research resources, further reinforcing the trend of industry concentration [4]